Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders

Brain Research Reviews

Volumn 27, Issue 3, 1998, Pages 257-267

  Qian, Zhong Ming ^a   Wang, Qin ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Brain iron accumulation; Ceruloplasmin; Divalent cation transporter; Lactotransferrin receptor; Melanotransferrin; Neurodegenerative disease

Indexed keywords

CARRIER PROTEIN; CERULOPLASMIN; DIVALENT CATION; IRON; LACTOFERRIN; MELANIN; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN METABOLISM; DEGENERATIVE DISEASE; HUMAN; HUNTINGTON CHOREA; IRON METABOLISM; IRON TRANSPORT; NERVE CELL NECROSIS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; BRAIN; CARRIER PROTEINS; CERULOPLASMIN; HUMANS; IRON; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; RECEPTORS, CELL SURFACE;

EID: 0010487727     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(98)00012-5     Document Type: Review

References (95)

1. R. Alemany, V.M. Rosa, C. Franc, G. Egea, F.X. Real, J.M. Thompsom, Glycosyl phosphatidylinositol membrane anchoring of melanotransferrin (p97): apical compartmentalization in intestinal epithelial cells, J. Cell. Sci. 104 (1993) 1155-1162.
2. E.N. Baker, S.V. Rumball, B.F. Anderson, Transferrin: insights into structure and function from studies on lactoferrin, Trends Biochem. Sci. 12 (1987) 350-353.
3. E.N. Baker, H.M. Baker, C.A. Smith, M.R. Stebbins, M. Kahn, K.E. Hellstrom, I. Hellstrom, Human melanotransferrin (p97) has only one functional iron-binding site, FEBS Lett. 298 (1992) 215-218.
4. W.A. Banks, A.J. Kastin, M.B. Fasold, C.M. Barrera, G. Augereau, Studies of the slow bidirectional transport of iron and transferrin across the blood-brain barrier, Brain Res. Bull. 21 (1988) 881-885.
5. J.L. Beard, J.R. Connor, B.C. Jones, Iron in the brain, Nutr. Rev. 52 (1993) 157-170.
6. J.L. Beard, J.R. Connor, B.C. Jones, Brain iron: location and function, Prog. Food. Nutr. Sci. 17 (1993) 183-221.
7. S.A. Benkovic, J.R. Connor, Ferrit, transferrin and iron in normal and aged rat brains, Anat. Rec. 232 (1992) 10A.
8. G. Benzi, A. Moretti, Are reactive oxygen species involved in Alzheimer's disease?, Neurobiol. Aging 16 (1995) 661-674.
9. B.G. Bleijenberg, H.G. von Eijk, B. Leijnse, The determination of non-heme iron and transferrin in cerebrospinal fluid, Clin. Chim. Acta 31 (1971) 277-281.
10. H. Bonkovsky, P. Ponka, B.R. Bacon, J. Drysdale, N.D. Grace, A.S. Tavill, An update on iron metabolism: summary of the fifth international conference on disorders on iron metabolism, Hepatology 24 (1996) 718-729.
11. D. Bonn, Pumping iron in Parkinson's disease, Lancet 347 (1996) 1614.
12. M.W.B. Bradbury, Transport of iron in the blood-brain-cerebrospinal fluid system, J. Neurochem. 69 (1997) 443-451.
13. J.P. Brown, K. Nishiyama, I. Hellstrom, K.E. Hellstrom, Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies, J. Immunol. 127 (1981) 539-546.
14. J.L. Casey, M.W. Hentze, D.M. Koeller, S.W. Caughman, T.A. Rouault, R.D. Klausner, J.B. Harford, Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation, Science 240 (1988) 924-928.
15. M. Cellier, G. Prive, A. Belouchi, T. Kwan, V. Rodrigues, W. Chia, P. Gros, Nramp defines a family of membrane proteins, Proc. Natl. Acad. Sci. USA 92 (1995) 10089-10093.
16. J.R. Connor, S.L. Menzies, S.M. Martin, E.L. Mufson, Cellular distribution of transferrin, ferritin and iron in normal and aged human brains, J. Neurosci. Res. 27 (1990) 595-611.
17. J.R. Connor, Proteins of iron regulation in the brain in Alzheimer's disease, in: R.B. Lauffer (Ed.), Iron and Human Diseases, CRC Press, Boca Raton, 1992, pp. 365-393.
18. J.R. Connor, S.L. Menzies, S.M. St. Martin, E.J. Mufson, A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brain, J. Neurosci. Res. 31 (1992) 75-83.
19. J.R. Connor, B.S. Snyder, J.L. Beard, R.E. Fine, E.J. Mufson, The regional distribution of iron and iron regulatory proteins in the brain in aging and Alzheimer's disease, J. Neurosci. Res. 31 (1992) 327-335.
20. J.R. Connor, P. Tucker, M. Johnson, B. Snyder, Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease, Neurosci. Lett. 159 (1993) 88-90.
21. J.R. Connor, Iron regulation in the brain at the cell and molecular level, Adv. Exp. Med. Biol. 356 (1994) 229-238.
22. J.R. Connor, B.S. Snyder, P. Arosio, D.A. Loeffler, P. Lewitt, A quantitative analysis of isoferritins in selectregions of aged, parkinsonian, and Alzheimer's diseased brains, J. Neurochem. 65 (1995) 717-724.
23. J.R. Connor, S.L. Menzies, Relationship of iron to oligodendrocytes and myelination, Glia 17 (1996) 83-93.
24. V.L. Dawson, T.M. Dawson, Free radicals and neuronal cell death, Cell Death Differ. 3 (1996) 71-78.
25. D.M. De Silva, C.C. Askwith, J. Kaplan, Molecular mechanisms of iron uptake in eukaryotes, Physiol. Rev. 76 (1996) 31-47.
26. D.T. Dexter, A. Carayon, M. Vidailhet, M. Rubert, F. Agid, Y. Agid, A.J. Lees, F.R. Wells, P. Jenner, C.D. Marsden, Decreased ferritin levels in Parkinson's disease, J. Neurochem. 55 (1990) 16-20.
27. D.T. Dexter, P. Jenner, A.H.V. Schapira, C.D. Marsden, Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia, Ann. Neurol. 32 (1992) S94-100.
28. T.K. Dickinson, J.R. Connor, Cellular distribution of iron, transferrin, and ferritin in the hypotransferremic (Hp) mouse brain, J. Comp. Neurol. 355 (1995) 67-80.
29. A.J. Dwork, E.A. Schon, J. Herbert, Nonidentical distribution of transferrin and ferric iron in Human brain, Neuroscience 27 (1988) 333-345.
30. 125I-ferro-transferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease, J. Neurochem. 60 (1993) 2338-2341.
31. 125I] ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys, Brain Res. 691 (1995) 115-124.
32. B.A. Faucheux, N. Nillesse, P. Damier, G. Spik, A. Mouatt-Prigent, A. Pierce, B. Leveugle, N. Kubis, J.J. Hauw, Y. Agid, E.C. Hirsch, Expression of lactoferrin receptors in increased in the mesencephalon of patients with Parkinson disease, Proc. Natl. Acad. Sci. USA 92 (1995) 9603-9607.
33. 125I-transferrin binding sites on perikarya of melanized neurons of the substantia is decreased in Parkinson's disease, Brain Res. 749 (1997) 170-174.
34. M.R. Food, S. Rothenberger, R. Gabathuler, I.D. Haidl, G. Reid, W.A. Jefferies, Transport and expression in human melanomas of a transferrin-like glycosylphosphatidylinositol-anchored protein, J. Biol. Chem. 269 (1994) 3034-3040.
35. B.B. Gelman, Iron in CNS disease, J. Neuropathol. Exp. Neurol. 54 (1995) 477-486.
36. M. Gerlach, D. Ben-Shachar, P. Riederer, M.B.H. Youdim, Altered brain metabolism of iron as cause of neurodegenerative diseases?, J. Neurochem. 63 (1994) 793-807.
37. J.M. Gorell, R.J. Ordidge, G.G. Brown, J.-C. Deniau, N.M. Buderer, J.A. Helpern, Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease, Neurology 45 (1995) 1138-1143.
38. M.E. Gotz, G. Kunig, P. Riederer, M.B. Youdim, Oxidative stress: free radical production in neural degeneration, Pharmacol. Ther. 63 (1994) 37-122.
39. S. Gruenheid, M. Cellier, S. Vidal, P. Gros, Identification and characterization of a second mouse Nramp gene, Genomics 25 (1993) 514-525.
40. H. Gunshin, B. Mackenzie, U.V. Berger, Y. Gunshin, M.F. Romero, W.F. Boron, S. Nussberger, J.L. Gollan, M.A. Hedlger, Cloning and characterization of a mammalian proton-coupled metal-ion transporter, Nature 388 (1997) 482-488.
41. E.D. Harris, The iron-copper connection: the link to ceruloplasmin grows stronger, Nutr. Rev. 53 (1995) 170-173.
42. Z.L. Harris, Y. Takahashi, H. Miyajima, M. Serizawa, R.T.A. MacGillivray, J.D. Gitlin, Aceruloplasminemia: molecular characterization of this disorder of iron metabolism, Proc. Natl. Acad. Sci. USA 92 (1995) 2529-2543.
43. Z.L. Harris, M.C. Migas, A.E. Hughes, J.I. Logan, J.D. Gitlin, Familial dementia due to a frameshift mutation in ceruloplasmin gene, Q. J. Med. 89 (1996) 355-359.
44. M.W. Hentze, L.C. Kuhn, Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress, Proc. Natl. Acad. Sci. USA 93 (1996) 8175-8182.
45. J.M. Hill, R.C. Switzer III, The regional distribution and cellular localization of iron in the rat brain, Neuroscience 11 (1984) 595-603.
46. J.M. Hill, The distribution of iron in the brain, in: M.B.H. Youdim (Ed.), Brain Iron: Neurochemical and Behavioural Aspects, Taylor and Francis, London (1988) pp. 1-24.
47. P.S. Hodgkins, J.A. Blair, Commentary: is Alzheimer's disease iron overload of the brain?, Alzheimer's Res. 3 (1997) 69-72.
48. J. Hu, J.R. Connor, Demonstration and characterization of the iron regulatory protein in human brain, J. Neurochem. 67 (1996) 838-844.
49. S. Iyer, B. Lonnerdal, Lactoferrin, lactoferrin receptors and iron metabolism, Eur. J. Clin. Nutr. 47 (1993) 232-241.
50. W.A. Jefferies, R. Gabathuler, S. Rotherberger, M. Food, M.L. Kennard, Pumping iron in the '90s, Trends Cell Biol. 6 (1996) 223-228.
51. W.A. Jefferies, M.R. Food, R. Gabathuler, S. Rothenberger, T. Yamada, O. Yasuhara, P.L. McGeer, Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin, Brain Res. 712 (1996) 122-126.
52. P. Jenner, Oxidative damage in neurodegenerative disease, Lancet 344 (1994) 796-798.
53. R.N. Kalaria, S.M. Sromek, I. Grahovac, S.I. Harik, Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease, Brain Res. 585 (1992) 87-93.
54. J. Kaplan, T.V. O'Halloran, Iron metabolism in Eukaryotes: Mars and Venus at it again, Science 271 (1996) 1510-1512.
55. J. Kaplan, Metal transport and unsafe sanctuary sites (Editorial), J. Clin. Invest. 98 (1996) 3-4.
56. T. Kawamata, I. Tooyama, T. Yamada, D.G. Walker, P.L. McGeer, Lacto-transferrin immunocytochemistry in Alzheimer and normal human brain, Am. J. Pathol. 142 (1993) 1574-1585.
57. T. Kawanami, T. Kato, M. Daimon, M. Tominaga, H. Sasaki, K. Maeda, S. Arai, Y. Shikama, T. Katagiri, Hereditary caeruloplasmin deficiency: clinicopathological study of a patient, J. Neurol. Neurosurg. Psychiatry 61 (1996) 506-509.
58. M.L. Kennard, D.R. Richardson, R. Gabathuler, P. Ponka, W.A. Jefferies, A novel iron uptake mechanism mediated by GPI-anchored human p97, EMBO J. 14 (1995) 4178-4186.
59. M.L. Kennard, H. Feldman, T. Yamada, W.A. Jefferies, Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease, Nature Med. 2 (1996) 1230-1235.
60. R.D. Klausner, T.A. Rouault, J.B. Harford, Regulating the fate of mRNA: the control of cellular iron metabolism, Cell 72 (1993) 19-28.
61. L.W.J. Klomp, J.D. Gitlin, Extression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia, Hum. Mol. Genet. 5 (1996) 1989-1996.
62. L.W.J. Klomp, Z.S. Farhangrazi, L.L. Dugan, J.D. Gitlin, Ceruloplasmin gene expression in the murine central nervous system, J. Clin. Invest. 98 (1996) 207-215.
63. B. Leveugle, G. Spik, D.P. Perl, C. Bouras, H.M. Fillit, P.R. Hof, The iron binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis, Brain Res. 650 (1994) 20-31.
64. B. Leveugle, B.A. Faucheux, C. Bouras, N. Nillesse, G. Spik, E.C. Hirsch, Y. Agid, P.R. Hof, Cellular distribution of the iron-binding protein lactoferrin in the mesencephalon of Parkinson's disease cases, Acta Neuropathol. 91 (1996) 566-572.
65. G.R. Lee, S. Nacht, J.N. Lukens, G.E. Cartwright, Iron metabolism in the copper deficient swine, J. Clin. Invest. 47 (1968) 2058-2069.
66. D.A. Loeffler, P.A. LeWitt, P.L. Juneau, A.A.F. Sima, H.U. Nguyen, A.J. DeMaggio, C.M. Brickman, G.J. Brewer, R.D. Dick, M.D. Troyer, L. Kanaley, Increased regional brain concentration of ceruloplasmin in neurodegenerative disorders, Brain Res. 738 (1996) 265-274.
67. J.I. Logan, Hereditary deficiency of ferroxidase (aka caeruloplasmin), J. Neurol. Neurosurg. Psychiatry 61 (1996) 431-432.
68. C. Morris, J.M. Candy, S. Omar, C.A. Bloxham, J.A. Edwardson, Transferrin receptors in the Parkinsonia midbrain, Neuropathol. Appl. Neurobiol. 20 (1994) 468-472.
69. S. Osaki, D.A. Johnson, E. Frieden, The possible role of the ferrous oxidase activity of ceruloplasmin in normal human serum, J. Biol. Chem. 241 (1966) 11490-11491.
70. A.P. Osmand, R.C. Switzer III, Differential distribution of lactoferrin and Alz-50 immunoreactivities in neuritic plaques and neurofibrillary tangles in Alzheimer's disease, in: K. Iqbal, R.C. McLachlan, B. Winblad, H.M. Wisniewski (Eds.), Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies, Wiley, New York, 1991, pp. 219-227.
71. A.D. Owen, A.H.V. Schapira, P. Jenner, C.D. Marsden, Oxidative stress and Parkinson's disease, Ann. NY Acad. Sci. 786 (1996) 217-223.
72. Z.M. Qian, P.L. Tang, Mechanisms of iron uptake by mammalian cells, Biochim. Biophys. Acta 1269 (1995) 205-214.
73. Z.M. Qian, Q. Wang, Y.M. Pu, Brain iron and neurological disorders, Chin. Med. J. 110 (1997) 455-458.
74. Z.M. Qian, P.L. Tang, Q. Wang, Iron crosses the endosomal membrane by a carrier-mediated process, Prog. Biophys. Mol. Biol. 67 (1997) 1-15.
75. G.D. Plowman, J.P. Brown, C.A. Enns, J. Schroder, B. Nikinmaa, H.H. Sussman, K.E. Hellstrom, I. Hellstrom, Assignment of the gene for human melanoma-associated antigen p97 to chromosome 3, Nature 303 (1983) 70-72.
76. G.W. Rebeck, S.D. Harr, D.K. Strickland, B.T. Hyman, Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha-macroglobulin receptor/low density lipoprotein receptor-related protein, Ann. Neurol. 37 (1995) 211-217.
77. P. Riederer, E. Sofic, W.D. Rausch, B. Schmidt, G.P. Reynolds, K. Jelinger, M.B.H. Youdim, Transition metal, ferritin, glutathione, and ascorbic acid in Parkinsonian brain, J. Neurochem. 52 (1989) 515-520.
78. P. Riederer, A. Dirr, E. Goetz, E. Sofic, K. Jellinger, M.B.H. Youdim, Distribution of iron in different regions and subcellular compartments in Parkinson's disease, Ann. Neurol. 32 (1992) s101-s104.
79. P. Riederer, K.W. Lange, Pathogenesis of Parkinson's disease, Curr. Opin. Neurol. Neurosurg. 5 (1992) 295-300.
80. H.P. Roeser, G.R. Lee, S. Nacht, G.E. Cartwright, The role of ceruloplasmin in iron metabolism, J. Clin. Invest. 49 (1970) 2408-2417.
81. S. Rothenberger, M.R. Food, R. Gabathuler, M.L. Kennard, T. Yamada, O. Yasuhara, P.L. Mcgeer, W.A. Jefferies, Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium, Brain Res. 712 (1996) 117-121.
82. P. Sachedv, The neuropsychiatry of brain iron, J. Neuropsychiatry 5 (1993) 18-29.
83. H.M. Schipper, Astrocytes, brain aging, and neurodegeneration, Neurobiol. Aging 17 (1996) 467-480.
84. D. Schubert, M. Chevion, The role of iron in beta amyloid toxicity, Biochem. Biophys. Res. Commun. 216 (1995) 702-707.
85. R. Sciot, R. De Vos, P. van Eyken, K. van der Steen, P. Moerman, V.J. Desmet, In situ localization of melanotransferrin (melanoma-associated antigen p97) in human liver: a light- and electronmicroscopic immunohistochemical study, Liver 9 (1989) 110-119.
86. Y. Takahashi, H. Miyajima, S. Shirabe, S. Nagataki, A. Suenaga, J.D. Gitlin, Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative diseases, Hum. Mol. Genet. 5 (1996) 81-84.
87. E.M. Taylor, E.H. Morgan, Developmental changes in transferrin and iron uptake by the brain in the rats, Dev. Brain Res. 55 (1990) 35-42.
88. 59Fe uptake into brain and cerebrospinal fluid and the influence thereon of antibodies against the transferrin receptor, J. Neurochem. 60 (1993) 106-113.
89. S. Vidal, D. Malo, K. Vogan, E. Skamene, P. Gros, Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg, Cell 73 (1995) 469-485.
90. S. Vidal, P. Gros, E. Skamene, Natural resistance to infection with intracellular parasites: molecular genetics identifies Nramp 1 as the Bcg/Ity/Lsh/locus, J. Leukocyte Biol. 58 (1995) 382-390.
91. K. Yoshida, K. Furihata, S. Takeda, A. Nakamura, K. Yamamoto, H. Morita, S. Hiyamuta, S. Ikeda, N. Shimizu, N. Yanagisawa, A mutation of the ceruloplasmin gene is associated with systemic hemosiderosis in humans, Nature Genet. 9 (1995) 267, 272.
92. M.B.H. Youdim, D. Ben-Shachar, The neurotoxic component in Parkinson's disease may involve iron-melanin interaction and lipid peroxidation of substantia nigra, in: P. Dostert, P. Riederer, M. Strolin-Benedetti, R. Roncucci (Eds.), Early Markers in Parkinson's and Alzheimer's Diseases, Springer-Verlag, Vienna, 1990, pp. 111-122.
93. M.B.H. Youdim, D. Ben-Shachar, P. Riederer, The possible role of iron in the etiopathology of Parkinson's disease, Mov. Disord. 8 (1993) 1-12.
94. M.B.H. Youdim, L. Lavie, P. Riederer, Oxygen free radicals and neurodegeneration in Parkinson's disease: a role for nitric oxide, Ann. NY Acad. Sci. 738 (1994) 64-68.
95. I. Zaitseva, V. Zaitseva, G. Card, K. Moshkov, B. Bax, A. Ralph, P. Lindley, The X-ray structure of human serum ceruloplasmin at 3.1 A: nature of the copper centers, J. Biol. Inorg. Chem. 1 (1996) 15-23.